Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLX-787-ODT for Muscle Cramps in MND
NCT03196375Phase 2Terminated
- Sponsor
- Salarius Pharmaceuticals
- Start
- Jul 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of FLX-787 in muscle cramps, sponsored by Salarius Pharmaceuticals. Started Jul 2017; status: terminated.
02
Drugs
FLX-787
03
Conditions
muscle cramps
Beyond the preview
Go deeper on NCT03196375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03196375.